Araştırma Makalesi


DOI :10.26650/EurJBiol.2025.1609925   IUP :10.26650/EurJBiol.2025.1609925    Tam Metin (PDF)

Ribonuclease A-Mineral Carrier Complex as a Potential Antitumor Preparation

Olga IlinskayaMikhail GlukhovGalina YakovlevaAntonina GaleevaWillam Kurdy

Objective: The oral administration of therapeutic proteins is complicated by their instability, which leads to loss of their activity in the gastrointestinal tract. Methods of protecting proteins from proteolysis are usually based on their encapsulation, which delays protein release in the stomach and intestines. Nevertheless, the protein is released immediately after capsule damage. The use of sorbents is particu larly promising because they provide prolonged protein release. The aim of this work was to create an organo-mineral preparation of antitumor ribonuclease (RNase) immobilised on hydrated aluminosilicate clinoptilolite, which is the safest agent with detoxifying, antioxidant, and anti-inflammatory properties among the numerous zeolites.

Materials and Methods: We developed a new method for processing natural clinoptilolite samples from Tatarsko-Shatrashanskoe deposit for use as sorbents for antitumor RNase A. Zeolites’ sorption capacity was analysed, their elemental composition was determined using scanning electron microscopy, images were created using transmission electron microscopy, and porosity was examined using X-ray computed tomography.

Results: We obtained a detailed characteristic of the mineral carrier and selected the optimal zeolite particle size and conditions for RNase A loading/unloading. The dynamics of RNase A release from clinoptilolite showed that the enzyme was gradually released over 20 h while maintaining its stability and catalytic activity in gastrointestinal fluids.

Conclusion: The combination of clinoptilolite detoxifying activity and antitumor activity of RNase A allows us to consider the obtained preparation not only as a factor of body nonspecific defence, but also as a promising antitumor drug supplementing well-known chemotherapeutic agents used in the treatment of neoplasms in the gastrointestinal tract.


PDF Görünüm

Referanslar

  • Usmani SS, Bedi G, SamueL JS, et aL. THPdb: Data-base of FDA-approved peptide and protein therapeutics. PLoS One. 2017;12(7):e0181748. doi:https://doi.org/10. 1371/journaL.pone.0181748 google scholar
  • Yamada T. Therapeutic monocLonaL antibodies. Keio J Med. 2011;60(2):37-46. doi: 10.2302/kjm.60.37 google scholar
  • Bhutani D, Vaishampayan UN. MonocLonaL antibodies in oncoLogy therapeutics: Present and future indications. Expert Opin Biol Ther. 2013;13(2):269-282. google scholar
  • IsLamova RR, YakovLeva GY, Tyurin AN, et aL. ZeoLites of the Tatarsko-Shatrashan deposit as carriers of modeL aLbumin for promising adsorption of therapeutic proteins. Zapiski RMO. 2022;151(1):105-113. google scholar
  • Khojaewa V, Lopatin O, ZeLenikhin P, ILinskaya O. ZeoLites as carriers of antitumor ribonucLease binase. Front Pharmacol. 2019;10:442. doi:10.3389/ fphar.2019.00442. google scholar
  • Ivanova II, Knyazeva EE. Micro-mesoporous materiaL obtained by zeoLite recrystaLLization: Synthesis, characterization and cataLyticaL appLications. Chem Soc Rev. 2013;42(9):3671-3688. google scholar
  • Attanoos RL, Churg A, GaLateau-SaLLe F, et aL. MaLignant mesotheLioma and its non-asbestos cause. Arch Pathol Lab Med. 2018;142(6):753-760. google scholar
  • Mastinu A, Kumar A, MaccarineLLi G, et aL. ZeoLite cLinoptiLoLite: Therapeutic virtues of an ancient mineraL. Molecules. 2019;24(8):1517. doi:10.3390/ moLecuLes24081517. google scholar
  • Kraljevic Pavelic S, Simovic Medica J, Gumbarevic D, Filosevic A, Przulj N, Pavelic K. CriticaL review on zeoLite cLinoptiLoLite safety and medicaL appLications in vivo. Front Pharmacol. 2018;9:1350. doi:https://doi.org/10.3389/fphar.2018.01350. google scholar
  • Hovhannisyan V, Siposova K, Musatov A, Chen SJ. DeveLopment of muLtifunctionaL nanocomposites for controLLed drug deLivery and hyperthermia. Sci Rep. 2021;11(1):5528. doi:10.1038/s41598-021-84927-x. google scholar
  • Siposova K, Huntosova V, SedLakova D, et aL. BiocompatibLe zeoLite-dye composites with anti-amyLoidogenic properties. Int J Biol Macromol. 2023;251:126331. doi:10.1016/j.ijbiomac.2023.126331. google scholar
  • Shen JH, Wang YS, Lin JP, Wu S-H, Horng JJ. Improving the indoor air quaLity of respiratory type of medicaL faciLity by zeoLite fiLtering. J Air Waste Manag Assoc. 2014;64(1):13-18. google scholar
  • Mousavi SM, Nezhad FF, AkmaL MH, et aL. Recent advances and synergistic effect of bioactive zeoLite imidazoLate frameworks (ZIFs) for biosensing appLications. Talanta. 2024;275:126097. doi:10.1016/j.taLanta.2024.126097. google scholar
  • Tain YL, Yang HW, Hou CY, Chang-Chien GP, Lin S, Hsu CN. Anti-hypertensive property of a no nanoparticLe in an adenine-induced chronic kidney disease young rat modeL. Antioxidants (Basel). 2023;12(2):513. doi:10.3390/ antiox12020513. google scholar
  • Gaur D, Swaminathan S, Batra JK. Interaction of human pancreatic ribonucLease with human ribonucLease inhibitor: Generation of inhibitor-resistant cytotoxic variant. JBC. 2001;276(27):24978-24984. google scholar
  • Mohamed ISE, Sen’kova AV, Markov OV, et aL. Bovine pancreatic RNase A: Insight in to the mechanism of antitumor activity in vitro and in vivo. Parmaceutics. 2022;14:1173. doi:10.3390/pharmaceutics14061173. google scholar
  • Dudkina EV, ULyanova VV, ILinskaya ON. SupramoLecuLar organization as a factor of ribonucLease cytotoxicity. Acta Naturae. 2020;12(3):24-33. google scholar
  • Akbarzadeh KM, Safary A, Barar J, et aL. PEGyLated goLd nanoparticLes-ribonucLease induced oxidative stress and apoptosis in coLorectaL cancer ceLLs. Bioimpacts. 2020;10(1):27-36. google scholar
  • Liu X, Wu F, Ji Y, Yin L. Recent advances in anti-cancer protein/peptide deLivery. Bioconjug Chem. 2019;30(2):305-324. google scholar
  • KoLpakov AI, ILyinskaya ON. Optimization of the method for determining ribonucLease activity using high poLymer RNA. Clin Lab Diagn. 1999;5:14-16. (in Russian). google scholar
  • Marques MRC, Loebenberg R, ALmukainzi M. SimuLated bioLogicaL fluids with possibLe appLication in dissoLution testing. Dissolution Technol. 2011;18(3):15-28. doi:dx.doi.org/10.14227/DT180311P15. google scholar
  • Cotter PD, Gahan CGM, HiLL C. A gLutamate decarboxyLase system protects Listeria monocytogenes in gastric fluid. Mol Microbiol. 2001;40(2):465-475. google scholar
  • Pearman JK, Biessy L, Howarth JD, et aL. Deciphering the moLecuLar signaL from past and aLive bacteriaL communities in aquatic sedimentary archives. Mol Ecol Resour. 2022;22(3):877-890. google scholar
  • Karnaukhova LI, Tupitsyn EN. UV spectroscopy of biological macromolecules (Educational manual). Ed. Saratov State University, Saratov, 2002, 15 p. (in Russian). google scholar
  • Goldring JP. Spectrophotometric methods to determine protein concentration. Methods Mol Biol. 2015;1312:41-47. google scholar
  • Xu W, Li LY, Grace JR. Dealumination of clinoptilolite and its effect on zinc removal from acid rock drainage. Chemosphere. 2014;111:427-433. google scholar
  • Kubasov AA. Zeolites are boiling stones. Soros Educ J. 1998;7:70-76. (in Russian). google scholar
  • Laurino C, Palmieri B. Zeolite: "The magic stone"; Main nutritional, environmental, experimental and clinical fields of application. Nutr Hosp. 2015;32(2):573-581. google scholar
  • Haemmerle MM, Tschegg C. Sorption of natural siderophores onto clinoptilolite-tuff and its controlled-release characteristics. Minerals. 2023;3(5):611. doi:10.3390/min13050611. google scholar
  • Cutovic M, Lazovic M, Vukovic-Dejanovic V, Nikolic D, Petronic-Markovic I, Cirovic D. Clinoptilolite for treatment of dyslipidemia: Preliminary efficacy study. J Altern Complement Med. 2017;23(9):738-744. doi:10.1089/acm.2016.0414. google scholar
  • Kontogiannidou E, Karavasili C, Kouskoura MG, et al. In vitro and ex vivo assessment of microporous faujasite zeolite (NaX-FAU) as a carrier for the oral delivery of danazol. J Drug Deliv Sci Technol. 2019;51:177-184. google scholar
  • Potgieter W, Samuels CS, Snyman JR. Potentiated clinoptilolite: Artificially enhanced aluminosilicate reduces symptoms associated with endoscopically negative gastroesophageal reflux disease and nonsteroidal anti-inflammatory drug induced gastritis. Clin Exp Gastroenterol. 2014;7:215-220. google scholar
  • Ivkovic S, Deutsch U, Silberbach A, Walraph E, Mannel M. Dietary supplementation with the tribomechanically activated zeolite clinoptilolite in immunodeficiency: Effects on the immune system. Adv Ther. 2004;21(2):135-147. google scholar
  • Mironova N, Patutina O, Brenner E, Kurilshikov A, Vlassov V, Zenkova M. The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy. Oncotarget. 2017;8(45):78796-78810. google scholar
  • Attila Ö, King HE, Meirer F, Weckhuysen BM. 3D Raman spectroscopy of large zeolite ZSM-5 crystals. Chemistry. 2019;25(29):7158-7167. google scholar
  • Yusof AM, Keat LK, Ibrahim Z, Majid ZA, Nizam NA. Kinetic and equilibrium studies of the removal of ammonium ions from aqueous solution by rice husk ash-synthesized zeolite Y and powdered and granulated forms of mordenite. J Hazard Mater. 2010;174(1-3):380-385. google scholar
  • Zhang Y, Wang F, Cao B, Yin H, Al-Tabbaa A. Simultaneous removal of Pb and MTBE by mixed zeolites in fixed-bed column tests. J Environ Sci (China). 2022;122:41-49. google scholar
  • Ilinskaya O, Ulyanova V, Lisevich I, et al. The native monomer of Bacillus pumilus ribonuclease does not exist extracellularly. Biomed Res Int. 2018;2018:4837623. doi:10.1155/2018/4837623. google scholar
  • Nguyen TTK, Pham KY, Yook S. Engineered therapeutic proteins for sustained-release drug delivery systems. Acta Biomater. 2023;171:131-154. google scholar
  • Nomicisio C, Ruggeri M, Bianchi E, et al. Natural and synthetic clay minerals in the pharmaceutical and biomedical fields. Pharmaceutics. 2023;15(5):1368. doi:10.3390/pharmaceutics15051368. google scholar
  • Villa CC, Valencia GA, Cördoba AL, Ortega-Toro R, Ahmed S, Gutierrez TJ. Zeolites for food applications: A review. Food Bioscience. 2022;46:101577. doi:10.1016/ j.fbio.2022.101577. google scholar
  • Jafary B, Akbarzadeh-Khiavi M, Farzi-Khajeh H, Safary A, Adibkia K. EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells. Sci Rep. 2025;15(1):1483. doi:10.1038/s41598-025-85856-9. google scholar
  • Ge S, Wang X, Zhao X, et al. Responsive multi-arm PEG-modified COF nanocomposites: Dynamic photothermal, pH/ROS dual-responsive, targeted carriers for rheumatoid arthritis treatment. Adv Healthc Mater. 2024;13(28):e2401744. doi:10.1002/adhm.202401744. google scholar
  • Jia J, Zhang S, Wen K, Li Q. Nano-Scaled Zeolitic imidazole framework-8 as an efficient carrier for the intracellular delivery of RNase A in cancer treatment. Int J Nanomedicine. 2019;14:9971-9981. google scholar
  • Khulood MT, Jijith US, Naseef PP, Kallungal SM, Geetha VS, Pramod K. Advances in metal-organic framework-based drug delivery systems. Int J Pharm. 2025;673:125380. doi:10.1016/j.ijpharm.2025.125380. google scholar
  • Pazarçeviren AE, Dikmen T, Altunbaş K, et al. Composite clinoptilolite/PCL-PEG-PCL scaffolds for bone regeneration: In vitro and in vivo evaluation. J Tissue Eng Regen Med. 2020;14(1):3-15. google scholar
  • Mohamed ISE, Sen'kova AV, Markov OV, et al. Bovine pancreatic RNase A: An insight into the mechanism of antitumor activity in vitro and in vivo. Pharmaceutics. 2022;14(6):1173. doi:10.3390/pharmaceutics14061173. google scholar
  • Li YC, Yamaguchi H, Liu YY, et al. Structural insights into EphA4 unconventional activation from prediction of the EphA4 and its complex with ribonuclease 1. Am J Cancer Res. 2022;12(10):4865-4878. google scholar
  • VIDAL Drug Information Systems. https://www.vidal.ru/drugs/ribonuclease__ 24326. Accessed March 15, 2025. google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Ilinskaya, O., Glukhov, M., Yakovleva, G., Galeeva, A., & Kurdy, W. (2019). Ribonuclease A-Mineral Carrier Complex as a Potential Antitumor Preparation. European Journal of Biology, 0(0), -. https://doi.org/10.26650/EurJBiol.2025.1609925


AMA

Ilinskaya O, Glukhov M, Yakovleva G, Galeeva A, Kurdy W. Ribonuclease A-Mineral Carrier Complex as a Potential Antitumor Preparation. European Journal of Biology. 2019;0(0):-. https://doi.org/10.26650/EurJBiol.2025.1609925


ABNT

Ilinskaya, O.; Glukhov, M.; Yakovleva, G.; Galeeva, A.; Kurdy, W. Ribonuclease A-Mineral Carrier Complex as a Potential Antitumor Preparation. European Journal of Biology, [Publisher Location], v. 0, n. 0, p. -, 2019.


Chicago: Author-Date Style

Ilinskaya, Olga, and Mikhail Glukhov and Galina Yakovleva and Antonina Galeeva and Willam Kurdy. 2019. “Ribonuclease A-Mineral Carrier Complex as a Potential Antitumor Preparation.” European Journal of Biology 0, no. 0: -. https://doi.org/10.26650/EurJBiol.2025.1609925


Chicago: Humanities Style

Ilinskaya, Olga, and Mikhail Glukhov and Galina Yakovleva and Antonina Galeeva and Willam Kurdy. Ribonuclease A-Mineral Carrier Complex as a Potential Antitumor Preparation.” European Journal of Biology 0, no. 0 (May. 2025): -. https://doi.org/10.26650/EurJBiol.2025.1609925


Harvard: Australian Style

Ilinskaya, O & Glukhov, M & Yakovleva, G & Galeeva, A & Kurdy, W 2019, 'Ribonuclease A-Mineral Carrier Complex as a Potential Antitumor Preparation', European Journal of Biology, vol. 0, no. 0, pp. -, viewed 24 May. 2025, https://doi.org/10.26650/EurJBiol.2025.1609925


Harvard: Author-Date Style

Ilinskaya, O. and Glukhov, M. and Yakovleva, G. and Galeeva, A. and Kurdy, W. (2019) ‘Ribonuclease A-Mineral Carrier Complex as a Potential Antitumor Preparation’, European Journal of Biology, 0(0), pp. -. https://doi.org/10.26650/EurJBiol.2025.1609925 (24 May. 2025).


MLA

Ilinskaya, Olga, and Mikhail Glukhov and Galina Yakovleva and Antonina Galeeva and Willam Kurdy. Ribonuclease A-Mineral Carrier Complex as a Potential Antitumor Preparation.” European Journal of Biology, vol. 0, no. 0, 2019, pp. -. [Database Container], https://doi.org/10.26650/EurJBiol.2025.1609925


Vancouver

Ilinskaya O, Glukhov M, Yakovleva G, Galeeva A, Kurdy W. Ribonuclease A-Mineral Carrier Complex as a Potential Antitumor Preparation. European Journal of Biology [Internet]. 24 May. 2025 [cited 24 May. 2025];0(0):-. Available from: https://doi.org/10.26650/EurJBiol.2025.1609925 doi: 10.26650/EurJBiol.2025.1609925


ISNAD

Ilinskaya, Olga - Glukhov, Mikhail - Yakovleva, Galina - Galeeva, Antonina - Kurdy, Willam. Ribonuclease A-Mineral Carrier Complex as a Potential Antitumor Preparation”. European Journal of Biology 0/0 (May. 2025): -. https://doi.org/10.26650/EurJBiol.2025.1609925



ZAMAN ÇİZELGESİ


Gönderim09.01.2025
Kabul02.04.2025
Çevrimiçi Yayınlanma09.05.2025

LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ



İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.